134 related articles for article (PubMed ID: 10613320)
41. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
42. Quantitative assessment of radiation dose and fractionation effects on normal tissue by utilizing a novel lung fibrosis index model.
Zhou C; Jones B; Moustafa M; Schwager C; Bauer J; Yang B; Cao L; Jia M; Mairani A; Chen M; Chen L; Debus J; Abdollahi A
Radiat Oncol; 2017 Nov; 12(1):172. PubMed ID: 29116014
[TBL] [Abstract][Full Text] [Related]
43. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
[TBL] [Abstract][Full Text] [Related]
44. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography.
Johnson CR; Thames HD; Huang DT; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):281-7. PubMed ID: 7673015
[TBL] [Abstract][Full Text] [Related]
45. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
Xiong W; Li J; Ma CM
Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
[TBL] [Abstract][Full Text] [Related]
46. The impact of delivered dose errors on local control of irradiated advanced laryngeal cancer.
Miszczyk L; Tarnawski R; Składowski K
Neoplasma; 2000; 47(2):133-6. PubMed ID: 10985482
[TBL] [Abstract][Full Text] [Related]
47. Volume and heterogeneity dependence of the dose-response relationship for head and neck tumours.
Agren Cronqvist AK; Källman P; Turesson I; Brahme A
Acta Oncol; 1995; 34(6):851-60. PubMed ID: 7576755
[TBL] [Abstract][Full Text] [Related]
48. Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors.
Milas L; Yamada S; Hunter N; Guttenberger R; Thames HD
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1195-202. PubMed ID: 1938517
[TBL] [Abstract][Full Text] [Related]
49. Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".
Wang CC; Efird J; Nakfoor B; Martins P
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):439-41. PubMed ID: 8655365
[TBL] [Abstract][Full Text] [Related]
50. Limitations of a TCP model incorporating population heterogeneity.
Warkentin B; Stavrev P; Stavreva NA; Fallone BG
Phys Med Biol; 2005 Aug; 50(15):3571-88. PubMed ID: 16030383
[TBL] [Abstract][Full Text] [Related]
51. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
52. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture.
Tarnawski R; Widel M; Skladowski K
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1074-81. PubMed ID: 12605987
[TBL] [Abstract][Full Text] [Related]
53. Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy.
Stavreva NA; Warkentin B; Stavrev PV; Fallone BG
Med Phys; 2005 Mar; 32(3):720-5. PubMed ID: 15839343
[TBL] [Abstract][Full Text] [Related]
54. Analytic investigation into effect of population heterogeneity on parameter ratio estimates.
Schinkel C; Carlone M; Warkentin B; Fallone BG
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1323-30. PubMed ID: 17884301
[TBL] [Abstract][Full Text] [Related]
55. Modelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapy.
Fiorino C; Cozzarini C; Rancati T; Briganti A; Cattaneo GM; Mangili P; Di Muzio NG; Calandrino R
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1250-7. PubMed ID: 25442349
[TBL] [Abstract][Full Text] [Related]
56. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825
[TBL] [Abstract][Full Text] [Related]
57. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
58. Loss of radiobiological effect of imaging dose in image guided radiotherapy due to prolonged imaging-to-treatment times.
Flynn RT
Med Phys; 2010 Jun; 37(6):2761-9. PubMed ID: 20632586
[TBL] [Abstract][Full Text] [Related]
59. Comparison of fractionation schedules in the large heterogeneity limit.
Guerrero M
Med Phys; 2009 Apr; 36(4):1384-8. PubMed ID: 19472645
[TBL] [Abstract][Full Text] [Related]
60. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
